BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22542954)

  • 1. Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors.
    Villar-Cheda B; Dominguez-Meijide A; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    Neurobiol Dis; 2012 Aug; 47(2):268-79. PubMed ID: 22542954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death.
    Borrajo A; Rodriguez-Perez AI; Villar-Cheda B; Guerra MJ; Labandeira-Garcia JL
    Neuropharmacology; 2014 Oct; 85():1-8. PubMed ID: 24878243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease.
    Rodriguez-Perez AI; Dominguez-Meijide A; Lanciego JL; Guerra MJ; Labandeira-Garcia JL
    Neurobiol Dis; 2013 Oct; 58():209-19. PubMed ID: 23774254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease.
    Joglar B; Rodriguez-Pallares J; Rodriguez-Perez AI; Rey P; Guerra MJ; Labandeira-Garcia JL
    J Neurochem; 2009 Apr; 109(2):656-69. PubMed ID: 19245663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease.
    Villar-Cheda B; Rodríguez-Pallares J; Valenzuela R; Muñoz A; Guerra MJ; Baltatu OC; Labandeira-Garcia JL
    Eur J Neurosci; 2010 Nov; 32(10):1695-706. PubMed ID: 20964730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.
    Garrido-Gil P; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    J Neuroinflammation; 2012 Feb; 9():38. PubMed ID: 22356806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells.
    Garrido-Gil P; Rodriguez-Pallares J; Dominguez-Meijide A; Guerra MJ; Labandeira-Garcia JL
    Exp Neurol; 2013 Dec; 250():384-96. PubMed ID: 24184051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.
    Rodriguez-Pallares J; Rey P; Parga JA; Muñoz A; Guerra MJ; Labandeira-Garcia JL
    Neurobiol Dis; 2008 Jul; 31(1):58-73. PubMed ID: 18499466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin.
    Borrajo A; Rodriguez-Perez AI; Diaz-Ruiz C; Guerra MJ; Labandeira-Garcia JL
    Glia; 2014 Jan; 62(1):145-57. PubMed ID: 24272709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease.
    Labandeira-Garcia JL; Rodríguez-Perez AI; Villar-Cheda B; Borrajo A; Dominguez-Meijide A; Guerra MJ
    Neuroscientist; 2015 Dec; 21(6):616-29. PubMed ID: 25323761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation.
    Rodriguez-Perez AI; Borrajo A; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL
    Glia; 2015 Mar; 63(3):466-82. PubMed ID: 25377425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging.
    Rodriguez-Perez AI; Borrajo A; Diaz-Ruiz C; Garrido-Gil P; Labandeira-Garcia JL
    Oncotarget; 2016 May; 7(21):30049-67. PubMed ID: 27167199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways.
    Lee DY; Oh YJ; Jin BK
    Glia; 2005 Aug; 51(2):98-110. PubMed ID: 15789435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treadmill exercise ameliorates dopaminergic neuronal loss through suppressing microglial activation in Parkinson's disease mice.
    Sung YH; Kim SC; Hong HP; Park CY; Shin MS; Kim CJ; Seo JH; Kim DY; Kim DJ; Cho HJ
    Life Sci; 2012 Dec; 91(25-26):1309-16. PubMed ID: 23069581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration.
    Villar-Cheda B; Valenzuela R; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    Neurobiol Aging; 2012 Jan; 33(1):204.e1-11. PubMed ID: 20888078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease.
    Chao YX; He BP; Tay SS
    J Neuroimmunol; 2009 Nov; 216(1-2):39-50. PubMed ID: 19819031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson's disease.
    Kinugawa K; Monnet Y; Béchade C; Alvarez-Fischer D; Hirsch EC; Bessis A; Hunot S
    J Neuroinflammation; 2013 Jul; 10():82. PubMed ID: 23844828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha.
    Sriram K; Matheson JM; Benkovic SA; Miller DB; Luster MI; O'Callaghan JP
    FASEB J; 2006 Apr; 20(6):670-82. PubMed ID: 16581975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
    Kubo K; Inada T; Shingu K
    Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.